Asmanex Inhalant
Product Images NDC 78206-114

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Asmanex (NDC 78206-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Asmanex 01)

Chemical structure of mometasone furoate, the active ingredient in ASMANEX inhalant. The diagram shows the arrangement of carbon, hydrogen, oxygen, chlorine atoms, and bonds depicting the molecular framework of this corticosteroid compound.*

FDA Label Image

Figure (Asmanex 02)

A line graph titled 'A 12-Week Trial in Patients Previously Maintained on Inhaled Beta2-agonists' showing mean change in FEV1 (L) over weeks. Two lines compare ASMANEX 220 mcg QD PM (solid line) versus placebo (dashed line). The graph displays higher mean FEV1 improvement for ASMANEX over 12 weeks with statistical significance indicated at multiple points.*

FDA Label Image

Figure (Asmanex 03)

A line graph titled 'Figure 2: A 12-Week Trial in Patients Previously Maintained on Inhaled Corticosteroids' showing mean change in FEV1 (L) over weeks for ASMANEX 220 mcg QD PM, ASMANEX 220 mcg BID, ASMANEX 440 mcg QD PM, and placebo groups. The graph plots improvement in lung function with ASMANEX treatments compared to placebo, with data points marked for statistical significance (P<.05).*

FDA Label Image

Figure (Asmanex 04)

A line graph showing the percent predicted FEV1 change from baseline over 12 weeks in children aged 4 to 11, comparing ASMANEX 110 mcg once daily in the evening with placebo. The graph shows mean change in % predicted FEV1 on the y-axis and different time points from baseline to endpoint on the x-axis. ASMANEX demonstrates an increasing improvement over time, while placebo shows minimal change.*

FDA Label Image

Figure (Asmanex 05)

Illustration of ASMANEX Twisthaler inhalant device showing two views: Figure A displays the inhaler upright with labeled parts including cap, dose counter, and base; Figure B shows the device with the cap removed, highlighting the mouthpiece and an indented arrow on the inhaler base.*

FDA Label Image

Figure (Asmanex 06)

An instructional illustration showing how to hold and open an Asmanex inhaler. It depicts a pair of hands holding the inhaler upright, twisting the cap counterclockwise to remove it, which loads the dose. Labels identify the cap and ventilation hole on the inhaler.*

FDA Label Image

Figure (Asmanex 07)

An instructional illustration showing the correct use of an ASMANEX inhalant device. A person is depicted inhaling the dose with a note to avoid covering the ventilation holes during inhalation.*

FDA Label Image

Figure (Asmanex 08)

Illustration showing how to close the ASMANEX TWISTHALER inhaler device. The image depicts a hand holding the inhaler, indicating that the indented arrow on the inhaler should align with the dose counter. It instructs to replace the cap and turn it clockwise until a click is heard.*

FDA Label Image

Principal Display Panel (220 mcg)

Packaging label for Asmanex Twisthaler inhalant, containing mometasone furoate inhalation powder at a strength of 220 mcg per actuation. The label shows a white and pink inhaler device image and indicates 120 metered doses. The manufacturer is Organon LLC. The label includes storage and usage instructions along with barcodes and regulatory text.*

FDA Label Image

Principal Display Panel (110 mcg)

Packaging label for Asmanex Twisthaler inhalant with 110 mcg mometasone furoate per actuation. The label includes images of the inhaler, dosage information stating 30 metered doses, and manufacturer details listing Organon LLC. It specifies oral inhalation route and prescription use only.*

FDA Label Image

Figure (Asmanex 11)

An instructional illustration showing a person closing the cap on an ASMANEX inhalant device. The text explains that a "click" sound indicates the cap is fully closed, ensuring the next dose is properly loaded in the inhaler.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.